Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Osteosarcoma × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 6 Obesity 3 Melanoma 3 Urinary Bladder Neoplasms 2 Neoplasms 2 Infertility 2 Adenocarcinoma Of Esophagus 2 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Posterior Fossa Ependymal Tumor 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Metabolic Diseases 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hyperandrogenism 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cytopenia 1

Interventions

fludarabine 5 Cyclophosphamide 5 Temozolomide 4 cabozantinib 3 Zoledronic Acid 3 Gemcitabine 3 Doxorubicin 3 irinotecan sucrosofate 2 atezolizumab 2 Vincristine 2 Sunitinib 2 Specimen Handling 2 Radiosurgery 2 Methotrexate 2 Irinotecan 2 Ifosfamide 2 Disulfiram 2 Cisplatin 2 Biopsy 2 vactosertib 1 trametinib 1 talazoparib 1 surufatinib 1 silmitasertib 1 selinexor 1 regorafenib 1 penpulimab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡